ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
110.98
+5.96 (5.68%)
At close: Oct 9, 2026, 4:00 PM EDT
110.87
-0.11 (-0.10%)
After-hours: Oct 9, 2026, 7:30 PM EDT
BIB Holdings Information
BIB is an equity ETF with a total of 256 individual holdings.
Total Holdings
256
Top 10 Percentage
159.14%
Asset Class
Equity
ETF Category
n/a
Assets
90.28M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 36.38% |
| 2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 31.59% |
| 3 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 29.45% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 20.34% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 19.37% |
| 6 | GILD | Gilead Sciences, Inc. | 4.90% |
| 7 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 4.85% |
| 8 | AMGN | Amgen Inc. | 4.62% |
| 9 | VRTX | Vertex Pharmaceuticals Incorporated | 4.50% |
| 10 | MRNA | Moderna, Inc. | 3.14% |
| 11 | REGN | Regeneron Pharmaceuticals, Inc. | 2.98% |
| 12 | RVMD | Revolution Medicines, Inc. | 1.61% |
| 13 | ILMN | Illumina, Inc. | 1.59% |
| 14 | BIIB | Biogen Inc. | 1.29% |
| 15 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.20% |
| 16 | RPRX | Royalty Pharma plc | 1.00% |
| 17 | ROIV | Roivant Sciences Ltd. | 0.99% |
| 18 | INCY | Incyte Corporation | 0.91% |
| 19 | UTHR | United Therapeutics Corporation | 0.91% |
| 20 | ARGX | argenx SE | 0.89% |
| 21 | GH | Guardant Health, Inc. | 0.89% |
| 22 | INSM | Insmed Incorporated | 0.88% |
| 23 | VTRS | Viatris Inc. | 0.80% |
| 24 | MEDP | Medpace Holdings, Inc. | 0.67% |
| 25 | EXEL | Exelixis, Inc. | 0.58% |
As of Oct 8, 2026